174 related articles for article (PubMed ID: 29327157)
1. Clinicopathological and prognostic significance of blood microvessel density in endometrial cancer: a meta-analysis and subgroup analysis.
Wang JZ; Xiong YJ; Man GCW; Chen XY; Kwong J; Wang CC
Arch Gynecol Obstet; 2018 Mar; 297(3):731-740. PubMed ID: 29327157
[TBL] [Abstract][Full Text] [Related]
2. Association of Tumor Size With Myometrial Invasion, Lymphovascular Space Invasion, Lymph Node Metastasis, and Recurrence in Endometrial Cancer: A Meta-Analysis of 40 Studies With 53,276 Patients.
Jin X; Shen C; Yang X; Yu Y; Wang J; Che X
Front Oncol; 2022; 12():881850. PubMed ID: 35719999
[TBL] [Abstract][Full Text] [Related]
3. Association of Myometrial Invasion With Lymphovascular Space Invasion, Lymph Node Metastasis, Recurrence, and Overall Survival in Endometrial Cancer: A Meta-Analysis of 79 Studies With 68,870 Patients.
Wang J; Xu P; Yang X; Yu Q; Xu X; Zou G; Zhang X
Front Oncol; 2021; 11():762329. PubMed ID: 34746002
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for pelvic lymph node metastasis in endometrial cancer.
Li Y; Cong P; Wang P; Peng C; Liu M; Sun G
Arch Gynecol Obstet; 2019 Oct; 300(4):1007-1013. PubMed ID: 31435773
[TBL] [Abstract][Full Text] [Related]
5. Lymphatic vessel involvement is predictive for lymph node metastasis and an important prognostic factor in endometrial cancer.
Wakayama A; Kudaka W; Matsumoto H; Aoyama H; Ooyama T; Taira Y; Arakaki Y; Shimoji Y; Nakasone T; Nishihira K; Kaneshima I; Tamaki T; Yoshimi N; Aoki Y
Int J Clin Oncol; 2018 Jun; 23(3):532-538. PubMed ID: 29275449
[TBL] [Abstract][Full Text] [Related]
6. Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials.
Bosse T; Peters EE; Creutzberg CL; Jürgenliemk-Schulz IM; Jobsen JJ; Mens JW; Lutgens LC; van der Steen-Banasik EM; Smit VT; Nout RA
Eur J Cancer; 2015 Sep; 51(13):1742-50. PubMed ID: 26049688
[TBL] [Abstract][Full Text] [Related]
7. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of lymphovascular space invasion in low-risk endometrial cancer.
Ayhan A; Şahin H; Sari ME; Yalçin I; Haberal A; Meydanli MM
Int J Gynecol Cancer; 2019 Mar; 29(3):505-512. PubMed ID: 30665899
[TBL] [Abstract][Full Text] [Related]
9. Prediction of lymphovascular space invasion in patients with endometrial cancer.
Kim SI; Yoon JH; Lee SJ; Song MJ; Kim JH; Lee HN; Jung G; Yoo JG
Int J Med Sci; 2021; 18(13):2828-2834. PubMed ID: 34220310
[No Abstract] [Full Text] [Related]
10. Nomogram with potential clinical use to predict lymph node metastasis in endometrial cancer patients diagnosed incidentally by postoperative pathological assessment.
Taşkın S; Şükür YE; Varlı B; Koyuncu K; Seval MM; Ateş C; Yüksel S; Güngör M; Ortaç F
Arch Gynecol Obstet; 2017 Oct; 296(4):803-809. PubMed ID: 28762064
[TBL] [Abstract][Full Text] [Related]
11. Lymphovascular space invasion (LVSI) is an isolated poor prognostic factor for recurrence and survival among women with intermediate- to high-risk early-stage endometrioid endometrial cancer.
Weinberg LE; Kunos CA; Zanotti KM
Int J Gynecol Cancer; 2013 Oct; 23(8):1438-45. PubMed ID: 24257558
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated macrophages correlate with vascular space invasion and myometrial invasion in endometrial carcinoma.
Soeda S; Nakamura N; Ozeki T; Nishiyama H; Hojo H; Yamada H; Abe M; Sato A
Gynecol Oncol; 2008 Apr; 109(1):122-8. PubMed ID: 18289648
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors and patterns of recurrence in lymphovascular space invasion positive women with stage IIIC endometriod endometrial cancer.
Cuylan ZF; Oz M; Ozkan NT; Comert GK; Sahin H; Turan T; Akbayir O; Kuscu E; Celik H; Dede M; Gungor T; Meydanli MM; Ayhan A
J Obstet Gynaecol Res; 2018 Jun; 44(6):1140-1149. PubMed ID: 29516573
[TBL] [Abstract][Full Text] [Related]
14. Magnitude of risk for nodal metastasis associated with lymphvascular space invasion for endometrial cancer.
Jorge S; Hou JY; Tergas AI; Burke WM; Huang Y; Hu JC; Ananth CV; Neugut AI; Hershman DL; Wright JD
Gynecol Oncol; 2016 Mar; 140(3):387-93. PubMed ID: 26768835
[TBL] [Abstract][Full Text] [Related]
15. Honing the classification of high-risk endometrial cancer with inclusion of lymphovascular space invasion.
Bendifallah S; Perrin M; Ouldamer L; Lavoué V; Canlorbe G; Raimond E; Hudry D; Coutant C; Graesslin O; Touboul C; Collinet P; Daraï E; Ballester M;
Surg Oncol; 2017 Mar; 26(1):1-7. PubMed ID: 28317578
[TBL] [Abstract][Full Text] [Related]
16. Lymphovascular space invasion is highly associated with lymph node metastasis and recurrence in endometrial cancer.
Hahn HS; Lee IH; Kim TJ; Lee KH; Shim JU; Kim JW; Lim KT
Aust N Z J Obstet Gynaecol; 2013 Jun; 53(3):293-7. PubMed ID: 23600915
[TBL] [Abstract][Full Text] [Related]
17. Lymphovascular Space Invasion Portends Poor Prognosis in Low-Risk Endometrial Cancer.
dos Reis R; Burzawa JK; Tsunoda AT; Hosaka M; Frumovitz M; Westin SN; Munsell MF; Ramirez PT
Int J Gynecol Cancer; 2015 Sep; 25(7):1292-9. PubMed ID: 26067863
[TBL] [Abstract][Full Text] [Related]
18. Statistical analysis of pathologic risk factors for intramyometrial lymphvascular space involvement in myoinvasive endometrial carcinoma.
Honoré LH; Hanson J
Int J Gynecol Cancer; 2006; 16(3):1330-5. PubMed ID: 16803525
[TBL] [Abstract][Full Text] [Related]
19. Lymphovascular space involvement is the sole independent predictor of lymph node metastasis in clinical early stage endometrial cancer.
Vaizoglu F; Yuce K; Salman MC; Basaran D; Calis P; Ozgul N; Usubutun A
Arch Gynecol Obstet; 2013 Dec; 288(6):1391-7. PubMed ID: 23764931
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for paraaortic lymph node metastasis in endometrial cancer.
Sari ME; Yalcin İ; Sahin H; Meydanli MM; Gungor T
Int J Clin Oncol; 2017 Oct; 22(5):937-944. PubMed ID: 28523533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
